DE60122350D1 - Benzoesaüre derivate und deren verwendung - Google Patents
Benzoesaüre derivate und deren verwendungInfo
- Publication number
- DE60122350D1 DE60122350D1 DE60122350T DE60122350T DE60122350D1 DE 60122350 D1 DE60122350 D1 DE 60122350D1 DE 60122350 T DE60122350 T DE 60122350T DE 60122350 T DE60122350 T DE 60122350T DE 60122350 D1 DE60122350 D1 DE 60122350D1
- Authority
- DE
- Germany
- Prior art keywords
- alkyl
- alkenyl
- coo
- alkoxy
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2320664 | 2000-09-21 | ||
CA2320664 | 2000-09-21 | ||
PCT/CA2001/001331 WO2002024674A1 (en) | 2000-09-21 | 2001-09-21 | Benzoic acid derivatives and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60122350D1 true DE60122350D1 (de) | 2006-09-28 |
DE60122350T2 DE60122350T2 (de) | 2007-12-06 |
Family
ID=4167219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60122350T Expired - Fee Related DE60122350T2 (de) | 2000-09-21 | 2001-09-21 | Benzoesaüre derivate und deren verwendung |
Country Status (8)
Country | Link |
---|---|
US (1) | US20050049202A1 (de) |
EP (1) | EP1318991B1 (de) |
JP (1) | JP2004509167A (de) |
AT (1) | ATE336487T1 (de) |
AU (1) | AU2001293555A1 (de) |
DE (1) | DE60122350T2 (de) |
ES (1) | ES2276829T3 (de) |
WO (1) | WO2002024674A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003088975A1 (en) * | 2002-04-17 | 2003-10-30 | The Burnham Institute | Inhibition of fatty acid synthase by beta-lactones and other compounds for inhibition of cellular proliferation |
US7728153B2 (en) | 2002-04-17 | 2010-06-01 | The Burnham Institute For Medical Research | Method for the asymmetric synthesis of beta-lactone compounds |
KR101310883B1 (ko) * | 2006-03-29 | 2013-09-25 | 삼성에스디아이 주식회사 | 다공성 금속 산화물 및 그 제조방법 |
US7597914B1 (en) * | 2007-10-02 | 2009-10-06 | Allen Jay Cohen | Ala-septic pre-cancerous liquid dissolving solution and method |
US8153171B1 (en) * | 2007-10-02 | 2012-04-10 | Allen Jay Cohen | Solution for dissolving pre-melanoma lesions and melanoma lesions including psoriasis, herpes simplex lesions and eczema lesions |
KR101217066B1 (ko) | 2010-06-29 | 2012-12-31 | 서울대학교산학협력단 | 벤조산 유도체를 포함하는, 간경변의 예방 또는 치료용 조성물 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE36477E (en) * | 1988-03-29 | 1999-12-28 | Taiho Pharmaceutical Co., Ltd. | Benzoic acid derivatives and process for preparing the same |
AU649275B2 (en) * | 1990-11-06 | 1994-05-19 | Bristol-Myers Squibb Company | Prodrugs for beta-lactamase and uses thereof |
DE4430212A1 (de) * | 1994-08-28 | 1996-02-29 | Merck Patent Gmbh | Ortho-substituierte Benzoesäure-Derivate |
US5767147A (en) * | 1995-04-21 | 1998-06-16 | The Regents Of The University Of California | Inhibition of glutathione transferase by haloenol lactones |
EP0875246A1 (de) * | 1997-04-04 | 1998-11-04 | Showa Denko Kabushiki Kaisha | Pharmazeutische Zusammensetzung aus Ascorbinsäurederivate zur Behandlung von Krebs |
-
2001
- 2001-09-21 DE DE60122350T patent/DE60122350T2/de not_active Expired - Fee Related
- 2001-09-21 WO PCT/CA2001/001331 patent/WO2002024674A1/en active IP Right Grant
- 2001-09-21 AU AU2001293555A patent/AU2001293555A1/en not_active Abandoned
- 2001-09-21 EP EP01973891A patent/EP1318991B1/de not_active Expired - Lifetime
- 2001-09-21 JP JP2002529084A patent/JP2004509167A/ja active Pending
- 2001-09-21 ES ES01973891T patent/ES2276829T3/es not_active Expired - Lifetime
- 2001-09-21 US US10/381,294 patent/US20050049202A1/en not_active Abandoned
- 2001-09-21 AT AT01973891T patent/ATE336487T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1318991A1 (de) | 2003-06-18 |
AU2001293555A1 (en) | 2002-04-02 |
DE60122350T2 (de) | 2007-12-06 |
WO2002024674A1 (en) | 2002-03-28 |
US20050049202A1 (en) | 2005-03-03 |
ATE336487T1 (de) | 2006-09-15 |
ES2276829T3 (es) | 2007-07-01 |
EP1318991B1 (de) | 2006-08-16 |
JP2004509167A (ja) | 2004-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200000837A2 (tr) | Anti-kanser bileşimleri hazırlamak için işlem ve ara maddeler. | |
HUP0400992A2 (hu) | Karbonsavval helyettesített oxazol-származékok, eljárás előállításukra és PPAR-alfa- és -gamma-aktivátorként való alkalmazásuk diabétesz kezelésére felhasználható gyógyszerek készítésére | |
RS50904B (sr) | Derivati tropana i njihova primena | |
AR012593A1 (es) | Pirrolopiridinas sustituidas, composicion farmaceutica que las contiene, procedimiento para su preparacion y el uso de las mismas en la manufacturade un medicamento | |
NO20101069L (no) | Anvendelse av visse NMDA-affinitetsantagonister som antidepressiva | |
ATE25682T1 (de) | Indol-3-carboxamid-derivate. | |
EP0322738A3 (de) | Benzyliden-Malononitril-Derivate zur Hemmung von proliferativen Prozessen in Säugetierzellen | |
SE8900039L (sv) | Isokinolinderivat, deras framstaellning och deras anvaendning | |
AR036864A1 (es) | Uso de compuestos de acido benzacepin-n-acetico, y procedimiento para la preparacion de dichos compuestos | |
BRPI0409959A (pt) | uso de derivados de azetidinacarboxamida em terapia | |
DK132188A (da) | Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika | |
HUP0003577A2 (hu) | Tetrahidro-gamma-karbolinok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
ATE336487T1 (de) | Benzoesaüre derivate und deren verwendung | |
IL160082A0 (en) | Quinoline derivatives and use thereof as antitumor agents | |
NO20022123L (no) | Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII | |
DE69720966D1 (de) | Benzo[c]chinolizin derivate,deren herstellung und verwendung als 5-alfa-reduktase inhibitoren | |
MY127036A (en) | Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3- trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity | |
ATE344237T1 (de) | Hydroxyacetamidobenzolsulfonamidderivate | |
TR200002831A2 (tr) | Kinolin-4-İl türevleri I | |
SE9904177D0 (sv) | Novel compounds | |
DE60210981D1 (de) | Heteroarylheteroalkylamin derivate und deren verwendung als inhibitoren der stickoxidsynthase | |
HU0103912D0 (en) | Use of substituted alkylpyridazinone derivatives for the preparation of pharmaceutical compositions with anxiolytic activity | |
HUP0200783A2 (hu) | Maduraftalazinszármazékok alkalmazása gyulladást okozó citokinin inhibitor hatású gyógyszerkészítmények előállítására | |
NO20042729L (no) | Heksasykliske forbindelser | |
HUP0002715A2 (hu) | Benzotiofénszármazékok alkalmazása trombocitaszám csökkentésére szolgáló gyógyszerkészítmények előállítására |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |